Related Experiment Videos
Role of mannoprotein in induction and regulation of immunity to Cryptococcus neoformans
D Pietrella1, R Cherniak, C Strappini
1Microbiology Section, Department of Experimental Medicine and Biochemical Sciences, University of Perugia, 06122 Perugia, Italy.
Abstract:
Our previous observations showed that mannoprotein (MP) induces early and massive production of interleukin-12 (IL-12) in vitro. This study was designed to investigate whether this phenomenon could be applied in vivo and to determine the biological significance of MP in Cryptococcus neoformans infection. The results reported here show that MP treatment induces IL-12 secretion by splenic macrophages and IL-12 p40 mRNA in the brain. During C. neoformans infection, MP reinforced IL-12 and IFN-gamma secretion that coincided with enhanced antifungal activity of natural effector cells, early resolution of the inflammatory process, and clearance of fungal load from the brain. These studies show that MP is a key inflammatory mediator that induces a protective immune response against C. neoformans infection. This information can be used to facilitate the design of a rational approach to manipulate the immune response to C. neoformans.
Insights
Mannoprotein (MP) boosts interleukin-12 (IL-12) production in vivo, enhancing immune response and fungal clearance during Cryptococcus neoformans infection. This suggests MP as a therapeutic target for cryptococcosis.
Area of Science:
- Immunology
- Mycology
- Infectious Diseases
Background:
- Mannoprotein (MP) from *Cryptococcus neoformans* was previously observed to induce significant interleukin-12 (IL-12) production *in vitro*.
- The role and biological significance of MP in the context of *C. neoformans* infection *in vivo* remained to be elucidated.
Purpose of the Study:
- To investigate the *in vivo* effects of MP on immune responses, specifically IL-12 production.
- To determine the biological significance of MP in modulating the host's defense against *C. neoformans* infection.
Main Methods:
- MP treatment was administered to assess its impact on IL-12 secretion by splenic macrophages and IL-12 p40 mRNA expression in the brain.
- The study evaluated the effects of MP during *C. neoformans* infection on IL-12 and IFN-gamma secretion, natural effector cell activity, inflammation resolution, and fungal load.
Main Results:
- MP treatment successfully induced IL-12 secretion by splenic macrophages and increased IL-12 p40 mRNA levels in the brain.
- During *C. neoformans* infection, MP administration enhanced the secretion of IL-12 and IFN-gamma.
- This enhancement correlated with improved antifungal activity, reduced inflammation, and decreased fungal burden in the brain.
Conclusions:
- Mannoprotein acts as a crucial inflammatory mediator that elicits a protective immune response against *Cryptococcus neoformans*.
- MP's ability to induce IL-12 and IFN-gamma suggests its potential as a therapeutic strategy for managing cryptococcosis.
- These findings provide a basis for developing targeted immunotherapies to combat *C. neoformans* infections.